Variant report
Variant | esv2421450 |
---|---|
Chromosome Location | chr4:158729437-158731374 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:38)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:38 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | ARID3A | chr4:158731106-158731793 | HepG2 | liver: | n/a | n/a |
2 | EP300 | chr4:158731167-158731741 | HepG2 | liver: | n/a | n/a |
3 | EP300 | chr4:158731290-158731665 | HepG2 | liver: | n/a | n/a |
4 | EP300 | chr4:158731196-158731670 | HepG2 | liver: | n/a | n/a |
5 | FOS | chr4:158731355-158731572 | MCF10A-Er-Src | breast: | n/a | n/a |
6 | FOS | chr4:158730312-158730453 | MCF10A-Er-Src | breast: | n/a | chr4:158730426-158730437 chr4:158730428-158730437 |
7 | FOS | chr4:158730310-158730589 | HUVEC | blood vessel: | n/a | chr4:158730426-158730437 chr4:158730428-158730437 |
8 | FOXA1 | chr4:158731156-158731955 | HepG2 | liver: | n/a | n/a |
9 | FOXA1 | chr4:158731147-158731737 | HepG2 | liver: | n/a | n/a |
10 | FOXA1 | chr4:158731174-158732022 | HepG2 | liver: | n/a | n/a |
11 | FOXA1 | chr4:158731139-158732019 | HepG2 | liver: | n/a | n/a |
12 | FOXA2 | chr4:158731247-158731696 | HepG2 | liver: | n/a | n/a |
13 | FOXA2 | chr4:158730966-158731915 | HepG2 | liver: | n/a | n/a |
14 | HDAC2 | chr4:158731237-158731724 | HepG2 | liver: | n/a | n/a |
15 | HDAC2 | chr4:158731242-158731697 | HepG2 | liver: | n/a | n/a |
16 | HNF4A | chr4:158731326-158731790 | HepG2 | liver: | n/a | n/a |
17 | HNF4A | chr4:158731334-158731728 | HepG2 | liver: | n/a | n/a |
18 | HNF4G | chr4:158731242-158731720 | HepG2 | liver: | n/a | n/a |
19 | HNF4G | chr4:158731280-158731735 | HepG2 | liver: | n/a | n/a |
20 | JUND | chr4:158731254-158731727 | HepG2 | liver: | n/a | n/a |
21 | MAFK | chr4:158731341-158731719 | HepG2 | liver: | n/a | n/a |
22 | MYBL2 | chr4:158731035-158731841 | HepG2 | liver: | n/a | n/a |
23 | MYC | chr4:158731275-158731575 | MCF10A-Er-Src | breast: | n/a | n/a |
24 | MYC | chr4:158731328-158731337 | MCF10A-Er-Src | breast: | n/a | n/a |
25 | NFIC | chr4:158731085-158731891 | HepG2 | liver: | n/a | n/a |
26 | NFIC | chr4:158731227-158731737 | HepG2 | liver: | n/a | n/a |
27 | POLR2A | chr4:158731238-158731265 | MCF10A-Er-Src | breast: | n/a | n/a |
28 | POLR2A | chr4:158731225-158731466 | MCF10A-Er-Src | breast: | n/a | n/a |
29 | RAD21 | chr4:158731266-158731565 | HepG2 | liver: | n/a | n/a |
30 | RAD21 | chr4:158731242-158731681 | HepG2 | liver: | n/a | n/a |
31 | RCOR1 | chr4:158731297-158731762 | HepG2 | liver: | n/a | n/a |
32 | RXRA | chr4:158731270-158731690 | HepG2 | liver: | n/a | n/a |
33 | SP1 | chr4:158731188-158731775 | HepG2 | liver: | n/a | n/a |
34 | STAT3 | chr4:158730299-158730445 | MCF10A-Er-Src | breast: | n/a | chr4:158730363-158730370 chr4:158730339-158730347 chr4:158730401-158730412 |
35 | TBP | chr4:158731317-158731733 | HepG2 | liver: | n/a | n/a |
36 | TCF7L2 | chr4:158731259-158731790 | HepG2 | liver: | n/a | n/a |
37 | TEAD4 | chr4:158731128-158731788 | HepG2 | liver: | n/a | n/a |
38 | ZEB1 | chr4:158731182-158731792 | HepG2 | liver: | n/a | n/a |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr4:158730340..158733222-chr4:158735249..158736822,2 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000249627 | TF binding region |
ENSG00000249627 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs570502824 | chr4:158729515-158729516 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs10517676 | chr4:158729559-158729560 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs527312182 | chr4:158729572-158729573 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs114300637 | chr4:158729636-158729637 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs560033573 | chr4:158729739-158729740 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs77512781 | chr4:158729747-158729748 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs183014519 | chr4:158729748-158729749 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs116786567 | chr4:158729777-158729778 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs374473770 | chr4:158729783-158729784 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs188560771 | chr4:158729805-158729806 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs7662544 | chr4:158729867-158729868 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs138506032 | chr4:158729887-158729888 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs149270909 | chr4:158729892-158729893 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs562407921 | chr4:158729909-158729910 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs144510967 | chr4:158729916-158729917 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs7662735 | chr4:158729944-158729945 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs116051002 | chr4:158729998-158729999 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs527523130 | chr4:158730031-158730032 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs535838182 | chr4:158730048-158730049 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs547286928 | chr4:158730075-158730076 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs570447671 | chr4:158730111-158730112 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs539413740 | chr4:158730162-158730163 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs10517677 | chr4:158730180-158730181 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs80292261 | chr4:158730224-158730225 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs535955336 | chr4:158730249-158730250 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs148399279 | chr4:158730296-158730297 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs572675779 | chr4:158730401-158730402 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs141612306 | chr4:158730414-158730415 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs145946937 | chr4:158730428-158730429 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs79817620 | chr4:158730459-158730460 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs552106625 | chr4:158730465-158730466 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs556126265 | chr4:158730496-158730497 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs10517678 | chr4:158730527-158730528 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
34 | rs543873063 | chr4:158730535-158730536 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs541898663 | chr4:158730571-158730572 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs561678397 | chr4:158730586-158730587 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs527461733 | chr4:158730589-158730590 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs13149222 | chr4:158730591-158730592 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs537910103 | chr4:158730606-158730607 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs375855910 | chr4:158730610-158730611 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs7680315 | chr4:158730619-158730620 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs371016351 | chr4:158730624-158730625 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs143522585 | chr4:158730698-158730699 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs554556140 | chr4:158730721-158730722 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs146724478 | chr4:158730727-158730728 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs549868610 | chr4:158730793-158730794 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
47 | rs13150049 | chr4:158730857-158730858 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs537151301 | chr4:158730867-158730868 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs549437910 | chr4:158730911-158730912 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs566209789 | chr4:158730912-158730913 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Lung cancer | 19208797 | CNVD |
Wilms tumour | 21544195 | CNVD |
Lung cancer | 18438408 | CNVD |
Cancer | 22429812 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Breast cancer | 16272173 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17133270 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20505237 | CNVD |
Breast cancer | 17393978 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Breast cancer | 21785460 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
small cell lung cancer | 20016488 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Breast cancer | 21633010 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Cancer | 20581869 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Breast cancer | 20409316 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 20164919 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Breast cancer | 21364760 | CNVD |
Autism | 20841430 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:158724800-158734400 | Weak transcription | Aorta | Aorta |
2 | chr4:158725600-158731000 | Weak transcription | Fetal Intestine Small | intestine |
3 | chr4:158725800-158731200 | Weak transcription | Liver | Liver |
4 | chr4:158727000-158731000 | Weak transcription | Fetal Intestine Large | intestine |
5 | chr4:158727000-158731400 | Weak transcription | Colon Smooth Muscle | Colon |
6 | chr4:158727200-158730200 | Weak transcription | HepG2 | liver |
7 | chr4:158728000-158730200 | Weak transcription | Rectal Smooth Muscle | rectum |
8 | chr4:158729600-158730400 | Enhancers | Pancreas | Pancrea |
9 | chr4:158729800-158730400 | Enhancers | HUVEC | blood vessel |
10 | chr4:158730200-158731400 | Enhancers | Rectal Smooth Muscle | rectum |
11 | chr4:158730200-158732800 | Enhancers | HepG2 | liver |
12 | chr4:158730800-158731000 | Enhancers | Stomach Mucosa | stomach |
13 | chr4:158731000-158732000 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
14 | chr4:158731000-158732000 | Enhancers | Fetal Intestine Small | intestine |
15 | chr4:158731000-158732000 | Weak transcription | Stomach Mucosa | stomach |
16 | chr4:158731000-158732200 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
17 | chr4:158731000-158732200 | Enhancers | Fetal Intestine Large | intestine |
18 | chr4:158731000-158732200 | Enhancers | Rectal Mucosa Donor 31 | rectum |
19 | chr4:158731200-158731600 | Enhancers | Duodenum Mucosa | Duodenum |
20 | chr4:158731200-158731800 | Enhancers | Liver | Liver |
21 | chr4:158731200-158732000 | Enhancers | Stomach Smooth Muscle | stomach |
22 | chr4:158731200-158732000 | Enhancers | HMEC | breast |